The global gene expression market attained a value of USD 14.68 Billion in 2025. The market is further expected to grow in the forecast period of 2026-2035 at a CAGR of 10.40%, to reach USD 39.48 Billion by 2035.
Base Year
Historical Period
Forecast Period
Expanding applications of next-generation technology including oncology studies, biomarker discovery, and personalized therapeutics are likely to augment market demand.
It is estimated that 35 million new cancer cases will arise by 2050. The rising inclination of patients towards precision oncology will positively influence the market dynamics.
Cost reductions of DNA sequencing has played a significant role in making gene expression more accessible and affordable. In June 2023, Illumina Inc. announced that technological advancements helped the company lower its cost of human genome sequencing (from USD 150,000 to USD 200).
Compound Annual Growth Rate
10.4%
Value in USD Billion
2026-2035
*this image is indicative*
The gene expression market growth is driven by the rapid advancements in the field of genomics. In pharmaceutical companies, gene expression analysis is increasingly employed for drug discovery and development to accommodate the clinical needs of the growing patient population. On the other hand, biotechnology companies are actively investing in the market to develop novel therapies. Additionally, the rising prevalence of chronic diseases such as cancer and the substantial funding for genomic research is expected to accelerate the market growth in the forecast period.
Growing preference for personalized medicine, rising demand for precision oncology, expansion of RNA sequencing applications, and increasing use of gene expression research in infectious disease research comprise some of the key trends and developments in the market.
Almac Diagnostic Services (a member of the contract development and manufacturing organization Almac Group) expanded its NGS portfolio of DNA sequencing service offerings by investing in Illumina NovaSeq X Plus in its Ireland facility.
Neoleukin Therapeutics, Inc., entered into a merger agreement with Neurogene Inc., a biotechnology company focused on the development of genetic medicines for rare neurological diseases. The merger is expected to strengthen the genetic drug pipeline of Neurogene Inc. and develop medications for rare diseases such as Rett Syndrome.
Illumina Inc. launched its first whole genome sequencing (WGS) assay called ‘Illumina Complete Long Read Prep Human’ that has been compatible with multiple sequencing systems. The product offers both long and short-read sequencing on the NovaSeq platform, along with simplified workflows and reduced DNA input requirements. Early customer data demonstrates high accuracy and flexibility, with the promotional price at USD 1,350 per whole genome.
Chroma Medicine, Inc., secured USD 135 million in series B financing led by Google Ventures. The firm plans to use the investment to expand its precision genomic medicines portfolio and develop its epigenetic editing technology.
The market demand is propelled by the application of gene expression technologies across various domains from basic research to diagnostics and drug discovery. Heightened patient awareness and increased accessibility to healthcare services further bolster the market demand. The rising prevalence of genetic disorders has increased the focus on gene expression studies to identify potential therapeutic targets. With the data suggesting that 72% of rare diseases have a genetic origin, the gene expression market size is projected to expand in the forecast period.
Technological advancements such as the integration of artificial intelligence (AI) and machine learning in gene expression analysis are anticipated to contribute to market growth. Such innovations will simplify complex data and assist in predicting treatment outcomes, facilitating the utilization of gene expression profiles in clinical decision-making.
“Global Gene Expression Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Breakup by Products and Services
Breakup by Technology
Breakup by Application
Breakup by End User
Breakup by Region
The key market players are contributing to the gene expression market growth through strategic mergers and acquisitions initiatives, novel product launches, and continuous research and development efforts aimed at providing improved patient solutions.
| Company | Year Founded | Headquarters | Products/Services |
| Illumina Inc | 1998 | San Diego, California, USA | Next-generation sequencing (NGS) systems, reagents, and related products for genetic and genomic analysis |
| Thermo Fisher Scientific | 1956 | Waltham, Massachusetts, USA | Waltham, Massachusetts, USA Products and services for research, analysis, discovery, and diagnostics, including gene expression solutions, sequencing, and life science reagents |
| Promega Corporation | 1978 | Madison, Wisconsin, USA | Reagents and systems for life sciences research, including gene expression analysis kits and assays |
| F. Hoffmann La Roche Ltd. | 1896 | Basel, Switzerland | Diagnostic and research tools, including systems and reagents for gene expression analysis |
Other key players in the market include Revvity Inc., Agilent Technologies Inc., Oxford Nanopore Technologies Inc., PacBio, QIAGEN, Bio-Rad Laboratories Inc., Danaher Life Sciences, and Takara Bio Inc.
In North America, the market is witnessing significant growth which can be attributed to robust research and development efforts aimed at expanding the genomics field. Major funding from the public and private sectors also supports the ongoing gene expression studies. In addition, the presence of a well-established healthcare system and growing demand for targeted therapies is expected to boost the gene expression market size in the forecast period.
Asia Pacific is projected to experience rapid growth in the coming years supported by the rising disposable income and improvement of healthcare facilities. Moreover, the regional market offers lucrative growth opportunities for the key market players due to various factors such as the huge population base, rising prevalence of chronic diseases, and increased expenditure on healthcare services and products.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 14.68 Billion in 2025 driven by advancements in gene expression analysis across the globe.
The market is anticipated to grow at a CAGR of 10.40% during the forecast period of 2026-2035, likely to reach a market value of USD 39.48 Billion by 2035.
The rising inclination of patients toward personalized medicines is fuelling the demand for the market.
One of the significant market trends is the increased acquisition and merger initiatives by the key market players. In July 2023, Neoleukin Therapeutics, Inc. entered into a merger agreement with Neurogene Inc. to expand their genetic drugs pipeline including NGN-401 for Rett Syndrome.
Based on the products and services, the market is segmented into consumables, instruments, and services.
Based on the technology, the market is segmented into polymerase chain reaction, next generation sequencing, and DNA microarray, among others.
Major end users of the market include pharmaceutical and biotechnology, academic and research institutes, diagnostic and clinical laboratories, among others.
Gene expression is used in disease diagnosis, drug discovery, and development, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Illumina Inc., Thermo Fisher Scientific, Promega Corporation, Revvity Inc., Agilent Technologies Inc., Oxford Nanopore Technologies Inc., F. Hoffmann La Roche Ltd., PacBio, QIAGEN, Bio-Rad Laboratories Inc., Danaher Life Sciences, and Takara Bio Inc.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Products and Services |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share